| DAA250 |
WD repeat and SOCS box-containing 2 |
WSB2 |
5.0% Decrease Gene Expression Level |
brain |
Human |
|
| DAA2078 |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) increases with age |
RELA |
60.0% Increase Gene Expression Level |
ovary |
Human |
|
| DAA195 |
v-ral simian leukemia viral oncogene homolog B (ras related; GTP binding protein) |
RALB |
7.0% Decrease Gene Expression Level |
brain |
Human |
|
| DAA2070 |
von Willebrand factor A domain containing 5A decreases with age |
VWA5A |
56.0% Decrease Gene Expression Level |
ovary |
Human |
|
| DAA247 |
voltage-dependent anion channel 1 |
VDAC1 |
10.0% Decrease Gene Expression Level |
brain |
Human |
|
| DAA249 |
visinin-like 1 |
VSNL1 |
6.0% Decrease Gene Expression Level |
brain |
Human |
|
| DAA248 |
vimentin |
VIM |
11.0% Increase Gene Expression Level |
brain |
Human |
|
| DAA565 |
vesicle transport through interaction with t-SNAREs homolog 1B (yeast) |
VTI1B |
3.0% Decrease Gene Expression Level |
skeletal muscle |
Human |
|
| DAA246 |
vesicle-associated membrane protein 3 (cellubrevin) |
VAMP3 |
7.0% Increase Gene Expression Level |
brain |
Human |
|
| DAA245 |
vesicle-associated membrane protein 2 (synaptobrevin 2) |
VAMP2 |
4.0% Decrease Gene Expression Level |
brain |
Human |
|
| DAA517 |
very low density lipoprotein receptor |
VLDLR |
4.0% Decrease Gene Expression Level |
skeletal muscle |
Human |
|
| DAA50 |
versican |
VCAN |
20.0% Increase Gene Expression Level |
brain |
Human |
|
| DAA423 |
vascular endothelial growth factor B |
VEGFB |
6.0% Decrease Gene Expression Level |
skeletal muscle |
Human |
|
| DAA2104 |
vacuolar protein sorting 13 homolog C (S. cerevisiae) decreases with age |
VPS13C |
58.7% Decrease Gene Expression Level |
ovary |
Human |
|
| DAA384 |
vacuolar protein sorting 13 homolog C (S. cerevisiae) |
VPS13C |
3.0% Increase Gene Expression Level |
skeletal muscle |
Human |
|
| DAA2106 |
uridine-cytidine kinase 1-like 1 increases with age |
UCKL1 |
86.0% Increase Gene Expression Level |
ovary |
Human |
|
| DAA1107 |
UDP-Gal:betaGal Beta 1,3-galactosyltransferase Polypeptide 6 |
B3GALT6 |
Increase DNA Methylation |
pons |
Human |
|
| DAA1108 |
UDP-Gal:betaGal Beta 1,3-galactosyltransferase Polypeptide 6 |
B3GALT6 |
Increase DNA Methylation |
temporal lobe |
Human |
|
| DAA1106 |
UDP-Gal:betaGal Beta 1,3-galactosyltransferase Polypeptide 6 |
B3GALT6 |
Increase DNA Methylation |
frontal lobe |
Human |
|
| DAA1105 |
UDP-Gal:betaGal Beta 1,3-galactosyltransferase Polypeptide 6 |
B3GALT6 |
Increase DNA Methylation |
cerebellum |
Human |
|
| DAA375 |
ubiquitin specific peptidase 6 (Tre-2 oncogene) |
USP6 |
5.0% Increase Gene Expression Level |
skeletal muscle |
Human |
|
| DAA2115 |
ubiquitin specific peptidase 42 increases with age |
USP42 |
60.0% Increase Gene Expression Level |
ovary |
Human |
|
| DAA491 |
ubiquitin-conjugating enzyme E2E 2 (UBC4/5 homolog, yeast) |
UBE2E2 |
5.0% Increase Gene Expression Level |
skeletal muscle |
Human |
|
| DAA2080 |
ubiquitin-conjugating enzyme E2D 2 (UBC4/5 homolog, yeast) decreases with age |
UBE2D2 |
48.2% Decrease Gene Expression Level |
ovary |
Human |
|
| DAA2090 |
ubiquitination factor E4B (UFD2 homolog, yeast) decreases with age |
UBE4B |
43.8% Decrease Gene Expression Level |
ovary |
Human |
|